Scandinavian ChemoTech AB Class B (8V6) Revenue
0 Followers
Scandinavian ChemoTech AB Class B Revenue
Scandinavian ChemoTech AB Class B had a revenue of 2.80M in the quarter ending Mar 31, 2026, with 5.66%. This bring the company's revenue in the last twelve months to 12.61M, Increased 2.65%. In the fiscal year ending Dec 31, 2025, Scandinavian ChemoTech AB Class B had annual revenue of 12.29M with 87.10% growth.
- Revenue (ttm)
- 12.61M
- Revenue Growth
- 6.01%
- P/S Ratio
- 0.40
- Revenue/Employee
- EUR 12,285,000
- Employees
- 1
- Market Cap
- EUR 4.91M
Revenue Chart
Scandinavian ChemoTech AB Class B Revenue - Annual
Revenue History
| Fiscal End Date | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 12.29M | 5.72M | 87.10% |
| Dec 31, 2024 | 6.57M | 3.74M | 132.67% |
| Dec 31, 2023 | 2.82M | 2.35M | 496.62% |
| Dec 31, 2022 | 473.00K | 424.00K | 865.31% |
| Dec 31, 2021 | 49.00K | -82.00K | -62.60% |
| Dec 31, 2020 | 131.00K | -425.00K | -76.44% |
| Dec 31, 2019 | 556.00K | -4.00K | -0.71% |
| Dec 31, 2018 | 560.00K | 532.76K | 1955.57% |
| Dec 31, 2017 | 27.24K | ― | ― |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.